Stockreport

ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include ANKTIVA for Papillary-Only NMIBC [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF announced that the National Comprehensive Cancer Network/NCCN updated its 2026 Clinical Practice Guidelines to include ANKTIVA (nogapendekin alfa inbakicept-pmln) in com [Read more]